Brett Trout Patents do not protect themselves. Novo Nordisk, one of the largest pharmaceutical companies in the world, just reminded us all how true that is. The Danish drugmaker let its Canadian patent on semaglutide lapse over a missed maintenance fee. That lapse is now set to cost the company billions of dollars. Semaglutide, better […]